In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Shire pays €428mm for public GI play Movetis

Executive Summary

In a move to enhance its gastrointestinal portfolio, specialty pharmaco Shire PLC is acquiring public Belgian firm Movetis NV, a Johnson & Johnson spin-off, paying €19 ($24.79) in cash (a 100% premium) for each of Movetis' 21mm outstanding shares. Including outstanding warrants, the value of the deal is €428mm.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register